Quantum Pharma PLC (LSE:QP.) - Overview

Stock Report

Quantum Pharma PLC QP.

Last Price
GBX41.88

Day Change
0.13|0.30%

As of 09/12/2016
16:20:14 GMT | GBX
Minimum 15 Minutes Delay.

Last Close41.75p
Day Range40.33 - 43.83
Mkt Cap70.83Mil
52-Wk Range32.75 - 112.00
Yield %1.79
ISINGB00BRTL8Q42
Volume27,729
P/E7.66
P/S0.75
P/CF7.50

Share Price

Total Returns 09/12/2016

 Chg (%)  
More ...
Quantum Pharma PLC4.69 
FTSE 100 TR GBP1.05
 
Financials
201420152016
More ...
Income Statement
Turnover53.4961.7269.99
Operating Profit2.286.676.96
Net Profit-1.910.725.60
Reported EPS-1.300.564.30
Balance Sheet
Current Assets17.9221.3322.84
Non Current Assets57.3061.2184.50
Total Assets75.2282.54107.35
Current Liabilities31.6916.3928.18
Total Liabilities79.1031.8251.84
Total Equity-3.8850.7255.51
Cash Flow
Operating Cash Flow4.592.927.61
Net Change in Cash-1.311.59-1.63
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
20176.904.86-11.188.63-0.771.443.44
20187.914.49-7.629.34-1.231.483.53
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
11/11/2016PurchaseMr Ian Johnson34.0058,82420,000.00
11/11/2016PurchaseDr. John Brown34.0073,52925,000.00
11/11/2016PurchaseChris Rigg34.00147,05950,000.00
10/03/2016PurchaseMr. Andrew Scaife68.0037,00025,160.00

Company Profile

Quantum Pharma PLC is engaged in the manufacture, procurement and supply to UK pharmacy chains, wholesalers and hospitals of Specials and Special Obtains. Specials are medicines which are not licensed for general manufacture.
 

Sector

Drug Manufacturers - Specialty & Generic

Market Position

970 of 1863 Companies

Index

FTSE AIM All Share

Outlook

(04/10/2016) "...the board now expects performance will be materially below market expectations"

Next Event 31/01/2017

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)9.2313.2516.09
Div Yld (E)3.524.244.23
PEG (E)-1.132.760.59
ROCE99.99202.9879.03
Op Mrgn12.13-16.14-13.33
EPS Grwth-8.1912.0522.92
Dividends
PreviousLatest
More ...
Record Date30/10/1521/10/16
Ex-Div29/10/1520/10/16
Paid20/11/1507/11/16
Amnt0.501.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr Ian Johnson
CEO & Chief Finance OfficerChris Rigg
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.